Vioxx Deal To Affect Other Merck Litigation: Experts
Though Friday's $4.85 billion settlement may bring an end to the bulk of the product liability litigation filed against Merck & Co. Inc. over painkiller Vioxx, the company remains entangled in...To view the full article, register now.
Already a subscriber? Click here to view full article